291
Views
16
CrossRef citations to date
0
Altmetric
Depression and Asthma

Airway Inflammation and Hypothalamic-Pituitary-Adrenal Axis Activity in Asthmatic Adults with Depression

, M.D., , M.D., , M.D., , , M.D., , M.D., , Ph.D. & , M.D., Ph.D. show all
Pages 274-281 | Published online: 04 Feb 2013

References

  • Loerbroks A, Herr RM, Subramanian S, Bosch JA. The association of asthma and wheezing with major depressive episodes: An analysis of 245 727 women and men from 57 countries. Int J Epidemiol 2012; 41:1436–1444.
  • Haczku A, Panettieri RA Jr. Social stress and asthma: The role of corticosteroid insensitivity. J Allergy Clin Immunol 2010; 125:550–558.
  • Gomulka K, Szczepaniak W. Problem of depression in patients with bronchial asthma. Pneumonol Alergol Pol 2012; 80:317–322.
  • Oraka E, King ME, Callahan DB. Asthma and serious psychological distress: Prevalence and risk factors among US adults, 2001–2007. Chest 2010; 137:609–616.
  • Ryu YJ, Chun EM, Lee JH, Chang JH. Prevalence of depression and anxiety in outpatients with chronic airway lung disease. Korean J Intern Med 2010; 25:51–57.
  • Scott KM, Bruffaerts R, Tsang A, Ormel J, Alonso J, Angermeyer MC, Benjet C, Bromet E, de Girolamo G, de Graaf R, Gasquet I, Gureje O, Haro JM, He Y, Kessler RC, Levinson D, Mneimneh ZN, Oakley Browne MA, Posada-Villa J, Stein DJ, Takeshima T, Von Korff M. Depression-anxiety relationships with chronic physical conditions: Results from the World Mental Health Surveys. J Affect Disord 2007; 103:113–120.
  • Lavoie KL, Bacon SL, Barone S, Cartier A, Ditto B, Labrecque M. What is worse for asthma control and quality of life: Depressive disorders, anxiety disorders, or both? Chest 2006; 130:1039–1047.
  • Nejtek VA, Brown ES, Khan DA, Moore JJ, van Wagner J, Perantie DC. Prevalence of mood disorders and relationship to asthma severity in patients at an inner-city asthma clinic. Ann Allergy Asthma Immunol 2001; 87:129–133.
  • Kullowatz A, Rosenfield D, Dahme B, Magnussen H, Kanniess F, Ritz T. Stress effects on lung function in asthma are mediated by changes in airway inflammation. Psychosom Med 2008; 70:468–475.
  • Sharma S, Sharma A, Kumar S, Sharma SK, Ghosh B. Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF-alpha levels. Am J Respir Cell Mol Biol 2006; 35:488–495.
  • van Lieshout RJ, Macqueen G. Psychological factors in asthma. Allergy Asthma Clin Immunol 2008; 4:12–28.
  • Espinosa Leal FD, Parra Roman M, Mendez NH, Toledo Nicolas DA, Menez Diaz D, Sosa Eroza E, Torres Salazar AB. Anxiety and depression in asthmatic adults in comparison to healthy individuals. Rev Alerg Mex 2006; 53:201–206.
  • Di Marco F, Santus P, Centanni S. Anxiety and depression in asthma. Curr Opin Pulm Med 2011; 17:39–44.
  • Priftis KN, Papadimitriou A, Nicolaidou P, Chrousos GP. Testing for hypothalamic-pituitary-adrenal axis suppression in asthmatic children. Pediatr Allergy Immunol 2008; 19:466–467; author reply 468–470.
  • Ringdal N, Lundback B, Alton M, Rak S, Eivindson A, Bratten G, Kjaersgaard P. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients. Respir Med 2000; 94:482–489.
  • Banki CM, Karmacsi L, Bissette G, Nemeroff CB. CSF corticotropin-releasing hormone and somatostatin in major depression: Response to antidepressant treatment and relapse. Eur Neuropsychopharmacol 1992; 2:107–113.
  • Hellhammer DH, Wust S, Kudielka BM. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology 2009; 34:163–171.
  • Bacci E, Cianchetti S, Carnevali S, Bartoli ML, Dente FL, Di Franco A, Giannini D, Vagaggini B, Paggiaro PL. Induced sputum is a reproducible method to assess airway inflammation in asthma. Mediators Inflamm 2002; 11:293–298.
  • Simpson JL, Wood LG, Gibson PG. Inflammatory mediators in exhaled breath, induced sputum and saliva. Clin Exp Allergy 2005; 35:1180–1185.
  • American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987; 136:225–244.
  • Nelson HS, Stricker W, Casale TB, Raff H, Fourre JA, Aron DC, Newman KB. A comparison of methods for assessing hypothalamic-pituitary-adrenal (HPA) axis activity in asthma patients treated with inhaled corticosteroids. J Clin Pharmacol 2002; 42:319–326.
  • Liard R, Leynaert B, Zureik M, Beguin FX, Neukirch F. Using global initiative for asthma guidelines to assess asthma severity in populations. Eur Respir J 2000; 16:615–620.
  • Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56–62.
  • Zheng YP, Zhao JP, Phillips M, Liu JB, Cai MF, Sun SQ, Huang MF. Validity and reliability of the Chinese Hamilton depression rating scale. Br J Psychiatry 1988; 152:660–664.
  • Knorr U, Vinberg M, Kessing LV, Wetterslev J. Salivary cortisol in depressed patients versus control persons: A systematic review and meta-analysis. Psychoneuroendocrinology 2010; 35:1275–1286.
  • Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47:25–29.
  • van Rensen EL, Stirling RG, Scheerens J, Staples K, Sterk PJ, Barnes PJ, Chung KF. Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma. Thorax 2001; 56:935–940.
  • Park SW, Jangm HK, An MH, Min JW, Jang AS, Lee JH, Park CS. Interleukin-13 and interleukin-5 in induced sputum of eosinophilic bronchitis: Comparison with asthma. Chest 2005; 128:1921–1927.
  • Heuser I, Deuschle M, Weber B, Stalla GK, Holsboer F. Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone. Psychoneuroendocrinology 2000; 25:513–518.
  • Kulkarni NS, Hollins F, Sutcliffe A, Saunders R, Shah S, Siddiqui S, Gupta S, Haldar P, Green R, Pavord I, Wardlaw A, Brightling CE. Eosinophil protein in airway macrophages: A novel biomarker of eosinophilic inflammation in patients with asthma. J Allergy Clin Immunol 2010; 126:61–69; e3.
  • Diamant Z, Boot JD, Mantzouranis E, Flohr R, Sterk PJ, Gerth van WR. Biomarkers in asthma and allergic rhinitis. Pulm Pharmacol Ther 2010; 23:468–481.
  • Hayden C, Pereira E, Rye P, Palmer L, Gibson N, Palenque M, Hagel I, Lynch N, Goldblatt J, Lesouëf P. Mutation screening of interferon-gamma (IFNgamma) as a candidate gene for asthma. Clin Exp Allergy 1997; 27:1412–1416.
  • Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002; 53:865–871.
  • Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Smit JH, Zitman FG, Penninx BW. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: Results from a large cohort study. Arch Gen Psychiatry 2009; 66:617–626.
  • Gold PW, Chrousos GP. The endocrinology of melancholic and atypical depression: Relation to neurocircuitry and somatic consequences. Proc Assoc Am Physicians 1999; 111:22–34.
  • Priftis KN, Papadimitriou A, Nicolaidou P, Chrousos GP. Dysregulation of the stress response in asthmatic children. Allergy 2009; 64:18–31.
  • Posener JA, DeBattista C, Williams GH, Chmura Kraemer H, Kalehzan BM, Schatzberg AF. 24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. Arch Gen Psychiatry 2000; 57:755–760.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.